A detailed history of Bey Douglas LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Bey Douglas LLC holds 5,175 shares of LLY stock, worth $4.2 Million. This represents 3.52% of its overall portfolio holdings.

Number of Shares
5,175
Previous 2,885 79.38%
Holding current value
$4.2 Million
Previous $2.56 Million 56.36%
% of portfolio
3.52%
Previous 2.28%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025

BUY
$727.2 - $932.06 $1.67 Million - $2.13 Million
2,290 Added 79.38%
5,175 $4 Million
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $2.23 Million - $2.77 Million
2,885 New
2,885 $2.56 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $771B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bey Douglas LLC Portfolio

Follow Bey Douglas LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bey Douglas LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bey Douglas LLC with notifications on news.